206 related articles for article (PubMed ID: 24029535)
1. Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder.
Lam RW; Parikh SV; Ramasubbu R; Michalak EE; Tam EM; Axler A; Yatham LN; Kennedy SH; Manjunath CV
Br J Psychiatry; 2013 Nov; 203(5):358-65. PubMed ID: 24029535
[TBL] [Abstract][Full Text] [Related]
2. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
3. The effect of remission status on work functioning in employed patients treated for major depressive disorder.
Sarfati D; Stewart K; Woo C; Parikh SV; Yatham LN; Lam RW
Ann Clin Psychiatry; 2017 Feb; 29(1):11-16. PubMed ID: 27901522
[TBL] [Abstract][Full Text] [Related]
4. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
Muhonen LH; Lönnqvist J; Juva K; Alho H
J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
[TBL] [Abstract][Full Text] [Related]
7. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
[TBL] [Abstract][Full Text] [Related]
8. Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.
Dunlop BW; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
J Affect Disord; 2018 Mar; 229():111-119. PubMed ID: 29306690
[TBL] [Abstract][Full Text] [Related]
9. Pre-treatment factor structures of the Montgomery and Åsberg Depression Rating scale as predictors of response to escitalopram in Indian patients with non-psychotic major depressive disorder.
Basu A; Chadda R; Sood M; Rizwan SA
Asian J Psychiatr; 2017 Aug; 28():154-159. PubMed ID: 28784374
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, 6-week prospective pilot study on the efficacy and safety of dose escalation in non-remitters in comparison to those of the standard dose of escitalopram for major depressive disorder.
Kim EY; Kim SH; Lee HJ; Lee NY; Kim HY; Park CHK; Ahn YM
J Affect Disord; 2019 Dec; 259():91-97. PubMed ID: 31445345
[TBL] [Abstract][Full Text] [Related]
11. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
[TBL] [Abstract][Full Text] [Related]
12. Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management.
Reynolds CF; Dew MA; Martire LM; Miller MD; Cyranowski JM; Lenze E; Whyte EM; Mulsant BH; Pollock BG; Karp JF; Gildengers A; Szanto K; Dombrovski AY; Andreescu C; Butters MA; Morse JQ; Houck PR; Bensasi S; Mazumdar S; Stack JA; Frank E
Int J Geriatr Psychiatry; 2010 Nov; 25(11):1134-41. PubMed ID: 20957693
[TBL] [Abstract][Full Text] [Related]
13. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
14. [Escitalopram for treatment of major depressive disorder in adults].
Llorca PM; Brousse G; Schwan R
Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716
[TBL] [Abstract][Full Text] [Related]
15. Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of change.
Farabaugh A; Fisher L; Nyer M; Holt D; Cohen M; Baer L; Shapero BG; Huz I; Cardoos A; Fava M; Alpert JE
Ann Clin Psychiatry; 2015 May; 27(2):118-26. PubMed ID: 25954938
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C
J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
Waugh J; Goa KL
CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
[TBL] [Abstract][Full Text] [Related]
19. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.
Kornstein SG; Li D; Mao Y; Larsson S; Andersen HF; Papakostas GI
CNS Spectr; 2009 Jun; 14(6):326-33. PubMed ID: 19668123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
